Strides Pharma buys four approved ANDAs from Nostrum Labs for over Rs 17 crore
Advertisement
Bengaluru: Strides Pharma Inc., a Step-down wholly-owned subsidiary of Strides Pharma Science Limited in the US, has acquired four approved Abbreviated New Drug Applications (ANDAs) from Nostrum Laboratories, Inc., USA., for more than Rs 17 crore for the US Market.
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs (Urinary Tract Infections), Pain Management, Allergy Symptoms and Attention Deficit Disorder (ADD/ ADHD) and Narcolepsy.
The cumulative market size for the acquired portfolio is ~USD 57 million, as per IQVIA data of 2025.
Total consideration for acquisition of the said ANDAs is USD 2.075 million (~INR 176 million).
"Two (out of the Four) ANDAs acquired are commercial products and is expected to be launched within 12 months. With access to these products, Strides will expand its portfolio of niche and difficult to manufacture products," the Company stated in a BSE filing.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.